HEADER SUGAR BINDING PROTEIN 02-APR-07 2YRO TITLE SOLUTION STRUCTURE OF THE C-TERMINAL GAL-BIND LECTIN PROTEIN FROM TITLE 2 HUMAN GALECTIN-8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAL-BIND_LECTIN DOMAIN; COMPND 5 SYNONYM: GAL-8, PROSTATE CARCINOMA TUMOR ANTIGEN 1, PCTA-1, PO66 COMPND 6 CARBOHYDRATE-BINDING PROTEIN, PO66-CBP; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS8; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P050613-32; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS GAL-BIND LECTIN, GALECTIN, SUGAR BINDING, STRUCTURAL GENOMICS, KEYWDS 2 NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, KEYWDS 4 SUGAR BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 16-MAR-22 2YRO 1 REMARK SEQADV REVDAT 2 24-FEB-09 2YRO 1 VERSN REVDAT 1 12-FEB-08 2YRO 0 JRNL AUTH T.TOMIZAWA,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE C-TERMINAL GAL-BIND LECTIN PROTEIN JRNL TITL 2 FROM HUMAN GALECTIN-8 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YRO COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000027048. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.28MM GAL-BINDING LECTIN U-15N, REMARK 210 13C; 20MM D-TRIS-HCL(PH 7.0); REMARK 210 100MM NACL; 1MM D-DTT; 0.02% REMARK 210 NAN3; 90% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9742, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY, TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 13 95.85 -69.77 REMARK 500 1 LYS A 56 45.68 33.09 REMARK 500 1 ASN A 67 -71.94 -35.73 REMARK 500 1 ASN A 87 106.66 -175.07 REMARK 500 1 ARG A 108 -33.75 -135.00 REMARK 500 1 HIS A 118 133.24 -37.32 REMARK 500 1 LYS A 123 154.46 -43.47 REMARK 500 1 ASP A 133 -35.19 -132.22 REMARK 500 1 ASP A 140 41.41 -107.49 REMARK 500 1 PRO A 152 -179.83 -69.69 REMARK 500 2 ASN A 24 -38.87 -39.49 REMARK 500 2 SER A 45 149.59 -176.03 REMARK 500 2 LYS A 54 -60.25 -100.69 REMARK 500 2 LYS A 56 45.41 37.88 REMARK 500 2 ASN A 67 -75.35 -39.16 REMARK 500 2 ARG A 108 -33.31 -135.01 REMARK 500 2 HIS A 124 91.98 -52.63 REMARK 500 2 SER A 130 31.18 -83.89 REMARK 500 2 ILE A 132 105.04 -55.21 REMARK 500 3 SER A 3 42.94 -93.70 REMARK 500 3 LYS A 56 45.63 33.79 REMARK 500 3 ASN A 67 -71.21 -34.90 REMARK 500 3 ARG A 108 -33.66 -134.96 REMARK 500 3 HIS A 118 108.79 -56.48 REMARK 500 3 HIS A 124 107.93 -59.30 REMARK 500 3 ASP A 133 -37.63 -134.61 REMARK 500 3 ASP A 140 44.18 -108.07 REMARK 500 3 GLU A 145 147.40 -174.87 REMARK 500 3 SER A 153 106.84 -42.62 REMARK 500 3 SER A 154 80.47 -67.35 REMARK 500 4 THR A 12 154.62 -43.17 REMARK 500 4 MET A 27 -178.36 -67.24 REMARK 500 4 LYS A 56 48.21 35.75 REMARK 500 4 ASN A 87 118.79 -168.25 REMARK 500 4 VAL A 107 24.98 49.14 REMARK 500 4 ARG A 108 -33.11 -134.96 REMARK 500 4 SER A 119 -66.40 -108.52 REMARK 500 4 LYS A 123 157.62 -41.48 REMARK 500 4 GLU A 128 103.76 -57.16 REMARK 500 4 ILE A 132 97.82 -56.37 REMARK 500 4 ASP A 140 41.05 -108.99 REMARK 500 4 GLU A 145 148.06 -172.31 REMARK 500 4 SER A 153 99.61 -66.20 REMARK 500 5 LYS A 56 44.52 32.21 REMARK 500 5 LYS A 69 51.56 38.96 REMARK 500 5 ARG A 86 84.63 -67.93 REMARK 500 5 PHE A 93 125.25 -31.53 REMARK 500 5 VAL A 107 25.05 48.44 REMARK 500 5 ARG A 108 -33.13 -135.00 REMARK 500 5 SER A 119 -59.61 -128.64 REMARK 500 REMARK 500 THIS ENTRY HAS 225 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSO002002300.3 RELATED DB: TARGETDB DBREF 2YRO A 8 149 UNP O00214 LEG8_HUMAN 175 316 SEQADV 2YRO GLY A 1 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 2 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 3 UNP O00214 EXPRESSION TAG SEQADV 2YRO GLY A 4 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 5 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 6 UNP O00214 EXPRESSION TAG SEQADV 2YRO GLY A 7 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 150 UNP O00214 EXPRESSION TAG SEQADV 2YRO GLY A 151 UNP O00214 EXPRESSION TAG SEQADV 2YRO PRO A 152 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 153 UNP O00214 EXPRESSION TAG SEQADV 2YRO SER A 154 UNP O00214 EXPRESSION TAG SEQADV 2YRO GLY A 155 UNP O00214 EXPRESSION TAG SEQRES 1 A 155 GLY SER SER GLY SER SER GLY PRO LYS SER GLY THR PRO SEQRES 2 A 155 GLN LEU SER LEU PRO PHE ALA ALA ARG LEU ASN THR PRO SEQRES 3 A 155 MET GLY PRO GLY ARG THR VAL VAL VAL LYS GLY GLU VAL SEQRES 4 A 155 ASN ALA ASN ALA LYS SER PHE ASN VAL ASP LEU LEU ALA SEQRES 5 A 155 GLY LYS SER LYS ASP ILE ALA LEU HIS LEU ASN PRO ARG SEQRES 6 A 155 LEU ASN ILE LYS ALA PHE VAL ARG ASN SER PHE LEU GLN SEQRES 7 A 155 GLU SER TRP GLY GLU GLU GLU ARG ASN ILE THR SER PHE SEQRES 8 A 155 PRO PHE SER PRO GLY MET TYR PHE GLU MET ILE ILE TYR SEQRES 9 A 155 CYS ASP VAL ARG GLU PHE LYS VAL ALA VAL ASN GLY VAL SEQRES 10 A 155 HIS SER LEU GLU TYR LYS HIS ARG PHE LYS GLU LEU SER SEQRES 11 A 155 SER ILE ASP THR LEU GLU ILE ASN GLY ASP ILE HIS LEU SEQRES 12 A 155 LEU GLU VAL ARG SER TRP SER GLY PRO SER SER GLY HELIX 1 1 GLU A 128 ILE A 132 5 5 SHEET 1 A 5 PHE A 19 ARG A 22 0 SHEET 2 A 5 THR A 134 GLY A 139 -1 O ILE A 137 N PHE A 19 SHEET 3 A 5 PHE A 46 LEU A 51 -1 N ASN A 47 O ASN A 138 SHEET 4 A 5 ILE A 58 ASN A 63 -1 O LEU A 60 N LEU A 50 SHEET 5 A 5 VAL A 72 PHE A 76 -1 O ASN A 74 N HIS A 61 SHEET 1 B 5 VAL A 117 LYS A 123 0 SHEET 2 B 5 GLU A 109 VAL A 114 -1 N PHE A 110 O TYR A 122 SHEET 3 B 5 TYR A 98 CYS A 105 -1 N ILE A 102 O ALA A 113 SHEET 4 B 5 THR A 32 VAL A 39 -1 N VAL A 33 O ILE A 103 SHEET 5 B 5 ILE A 141 TRP A 149 -1 O HIS A 142 N GLU A 38 CISPEP 1 LEU A 17 PRO A 18 1 -0.12 CISPEP 2 LEU A 17 PRO A 18 2 -0.13 CISPEP 3 LEU A 17 PRO A 18 3 -0.12 CISPEP 4 LEU A 17 PRO A 18 4 -0.06 CISPEP 5 LEU A 17 PRO A 18 5 -0.14 CISPEP 6 LEU A 17 PRO A 18 6 -0.08 CISPEP 7 LEU A 17 PRO A 18 7 -0.14 CISPEP 8 LEU A 17 PRO A 18 8 -0.13 CISPEP 9 LEU A 17 PRO A 18 9 -0.13 CISPEP 10 LEU A 17 PRO A 18 10 -0.09 CISPEP 11 LEU A 17 PRO A 18 11 -0.13 CISPEP 12 LEU A 17 PRO A 18 12 -0.06 CISPEP 13 LEU A 17 PRO A 18 13 -0.19 CISPEP 14 LEU A 17 PRO A 18 14 -0.19 CISPEP 15 LEU A 17 PRO A 18 15 -0.12 CISPEP 16 LEU A 17 PRO A 18 16 -0.13 CISPEP 17 LEU A 17 PRO A 18 17 -0.13 CISPEP 18 LEU A 17 PRO A 18 18 -0.20 CISPEP 19 LEU A 17 PRO A 18 19 -0.11 CISPEP 20 LEU A 17 PRO A 18 20 -0.12 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1